The evolution of consultation practices with general practitioners and nephrologists for patients with chronic kidney disease before and after the COVID-19 pandemic in France
Juliette Piveteau, Sahar Bayat, Cécile Vigneau, Cécile Couchoud, Maxime Raffray

TL;DR
This study examines how the care of patients with chronic kidney disease in France changed before and after the COVID-19 pandemic, focusing on consultations and hospitalizations.
Contribution
The study provides new insights into the adaptation of outpatient care for CKD patients in France during the pandemic using national health data.
Findings
Teleconsultations helped maintain outpatient care for CKD patients during lockdown periods.
Hospitalizations decreased by 10% during the pandemic, raising questions about the reasons for reduced inpatient care.
Consultation rates with general practitioners and nephrologists remained stable despite pandemic disruptions.
Abstract
The COVID-19 pandemic led to concerns about disruptions in the follow-up of chronic diseases, including chronic kidney disease (CKD). Here, we assessed the COVID-19 pandemic impact on healthcare use by patients with CKD in France. We used the French National Health Data System (SDNS) that contains data on outpatient and inpatient healthcare of the whole French population. Using a validated algorithm, we identified two CKD cohorts based on their healthcare utilization: (i) the 2019 cohort (pandemic-exposed) and (ii) the 2017 cohort (comparator). We followed these cohorts for 2 years and compared consultations (in-person and teleconsultation) with a general practitioner (GP) and a nephrologist and all-cause hospitalizations (excluding COVID-19 as primary diagnosis). We stratified comparisons by age group and sex. We identified 4,866,096 individuals with CKD in 2017 and 5,089,706 in…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · Healthcare cost, quality, practices · Chronic Disease Management Strategies
